Literature DB >> 9213171

Patent ductus arteriosus with combined valvular disease at age 91.

T Satoh1, Y Yanagitani, Y Okano.   

Abstract

This report describes a 91-year-old patient with patent ductus arteriosus (PDA) complicated by combined valvular disease (CVD) (aortic and mitral stenosis, and aortic, mitral, pulmonic and tricuspid regurgitation). This patient seems to be the oldest living female with PDA and CVD hitherto reported in the medical literature. The patient developed several bouts of congestive heart failure which were treated medically. She not only has survived without surgical management, but is still enjoying her life at age 91. The features of PDA in the elderly are reviewed.

Entities:  

Mesh:

Year:  1997        PMID: 9213171     DOI: 10.2169/internalmedicine.36.340

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Silent patent ductus arteriosus incidentally found before balloon mitral valvotomy for severe rheumatic mitral stenosis.

Authors:  Dhabaleswar Sahoo; Sudeep Kumar; Aditya Kapoor
Journal:  J Cardiol Cases       Date:  2016-03-02

2.  Multiple thromboembolism with multiple causes in a 69-year-old woman: a case report.

Authors:  Luigi Iuliano; Maria Misuraca; Alessandro Varroni; Massimo Raponi; Marco Massucci; Alessandro Pagnanelli; Giuseppe Cimino; Giovanni Bertoletti
Journal:  J Med Case Rep       Date:  2011-05-14

3.  A case of patent ductus arteriosus with congestive heart failure in a 80-year-old man.

Authors:  Hye Yeon Lee; Sung-Ho Her; Mahn Won Park; Min Seok Choi; Jung Sun Cho; Chan Joon Kim; Hye Seon Kang; Yoo A Choi; Il Nam Ju; Seon A Kim; Jong-Ho Lee; Jong-Bum Kwon; Kuhn Park
Journal:  Korean Circ J       Date:  2012-12-31       Impact factor: 3.243

4.  Adult patent ductus arteriosus : An unusual cause of heart failure in an octogenarian female.

Authors:  Silvana Mueller; Fabian Plank; Katrin Klimes; Gudrun Feuchtner; Johannes Mair
Journal:  Wien Klin Wochenschr       Date:  2016-08-26       Impact factor: 1.704

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.